High levels of adherence to study medication among women who conceived during HIV PrEP study
PrEP users say it provides an 'extra layer of protection' and 'peace of mind'
Model shows potential for substantial long-term HIV risk for serodifferent couples, even with new prevention tools
Tenofovir HIV PrEP causes no long-term harm to kidneys
Daily dosing key to the efficacy of tenofovir-based HIV PrEP
No significant risk of resistance if HIV infection occurs during use of Truvada PrEP
PROUD UK PrEP study completes enrolment – first data give participants' background and risk factors
Monkey studies confirm viability of injectable PrEP drug
